Plain-English translation of NCT07511413 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This research study is watching how nutrition, muscle, and body composition change in patients receiving standard cancer treatment for head and neck cancer, lung cancer, or rectal cancer. Researchers are not testing a new drug โ instead, they're collecting detailed information about what patients eat, how their bodies change, and how well they tolerate their regular treatment. The goal is to gather real-world information that could help design better nutritional support strategies for cancer patients in the future.
Cancer treatment can significantly affect how patients eat, their muscle mass, and their overall nutrition โ but doctors don't yet have enough detailed information about these changes to know the best way to support patients. This study aims to fill that gap by carefully documenting nutrition and body changes so that future studies can test whether special nutritional interventions might help patients feel better and handle treatment more easily.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would visit the study center at several time points โ starting before your cancer treatment begins and continuing through your treatment and follow-up. At each visit, you'll have dietary consultations where you'll keep food records, complete nutrition screenings, and have your body composition measured using a safe, non-invasive machine. You'll also do a handgrip strength test, answer questions about your quality of life and any treatment side effects, and have a small blood sample taken. The whole process is designed to create a detailed picture of how your nutrition and body change during your cancer care.
AI-generated summary from trial data ยท Jun 13, 2026 ยท Not medical advice
Italy
Sponsor
Fondazione del Piemonte per l'Oncologia
Enrollment target
~110 participants
Started
September 2024
Primary completion
August 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Valentina Casalone, MD
Fondazione del Piemonte per l'Oncologia
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.